14410 Impact of mirikizumab maintenance dosing at week 104 on health-related quality of life in patients who had less than PASI 90 response at week 16: A phase 2 study analysis
Bagel, Jerry, Reich, Kristian, Rich, Phoebe, Bissonnette, Robert, Ohata, Chika, Papp, Kim Alexander, Patel, Dipak R., Zhu, Baojin, Edson-Heredia, Emily, Gooderham, MelindaVolume:
83
Journal:
Journal of the American Academy of Dermatology
DOI:
10.1016/j.jaad.2020.06.636
Date:
December, 2020
File:
PDF, 332 KB
2020